Trazodone - Award Notice
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-26-D-0013
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the procurement of Trazodone, a pharmaceutical product. This award is identified by procurement number SPE2D2-26-D-0013 and falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing. The associated Product Service Code is 6505, indicating drugs and biologicals.
The place of performance for this contract is Chantilly, Virginia, United States. The DLA Troop Support office is the contracting entity responsible for overseeing the fulfillment of this award. The notice is currently active and was posted on April 28, 2026.
The primary objective of this procurement is to secure a reliable supply of Trazodone, ensuring that the Department of Defense and its associated agencies have access to this essential pharmaceutical. The scope of the contract likely includes the manufacturing, supply, and delivery of Trazodone in accordance with federal standards and requirements, although specific quantities, packaging, and delivery schedules are not detailed in the notice.
Key requirements for contractors would include compliance with pharmaceutical manufacturing regulations, quality assurance standards, and the ability to deliver to the specified location in Chantilly, Virginia. The expected deliverables are the timely and consistent provision of Trazodone as outlined in the contract award.
For further information or clarification regarding this award, interested parties may contact Nancy Fernandez ([email protected], 445-737-0713) or Jason Wray ([email protected], 445-737-6304), who serve as the primary and secondary points of contact, respectively.
This procurement is classified as an award notice, indicating that the contract has already been granted. No set-aside requirements or special considerations are specified in the provided information. Contractors evaluating this opportunity should note that the core elements—pharmaceutical manufacturing, delivery to Chantilly, Virginia, and compliance with federal standards—will remain constant throughout the contract lifecycle.
Additional details and the official award documentation can be accessed via the SAM.gov opportunity ID f0ff6656df33409ea7e110b7b0d478ed at the following URL: https://sam.gov/opp/f0ff6656df33409ea7e110b7b0d478ed/view.